Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Sanofi Could Be on a Roll With a Strong Performance and Its Latest FDA Approval
07:05am, Monday, 06'th Mar 2023
Altuviiio is indicated to prevent and control bleeding episodes in hemophilia patients. In 2022, Sanofi saw business EPS grow more than 17% year over year.
5 Stocks With Amazingly Low EV-to-EBITDA Ratios to Snap Up
06:47am, Monday, 27'th Feb 2023
We have screened value stocks JKS, UFPI, ASX, BBCP and SNY based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential.
Sanofi gets FDA approval for hemophilia drug
01:55am, Friday, 24'th Feb 2023
By Adria Calatayud
Where To Invest $10,000 Right Now?
08:47am, Tuesday, 21'st Feb 2023
This article is built around one key question: Where would you put $10,000 right now? I started by assessing the parameters of this question and presented interesting value-adding answers for my Twitt
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
12:48pm, Friday, 17'th Feb 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
New Strong Buy Stocks for February 7th
09:02am, Tuesday, 07'th Feb 2023
DLAKY, UBS, SNY, EVR and TME have been added to the Zacks Rank #1 (Strong Buy) List on February 7, 2022.
SNY Stock: 2.58% Decrease Explained
06:33am, Monday, 06'th Feb 2023
The stock price of Sanofi (NASDAQ: SNY) fell by 2.58% in the most recent trading session. This is why.
Sanofi SA (SNY) Q4 2022 Earnings Call Transcript
03:08pm, Friday, 03'rd Feb 2023
Sanofi SA (NASDAQ:SNY ) Q4 2022 Results Conference Call February 3, 2023 8:00 AM ET Company Participants Eva Schaefer-Jansen - Head, IR Paul Hudson - CEO Bill Sibold - EVP, Specialty Care and Presiden
Regeneron Pharma Outplays Fourth-Quarter Decline, But Sanofi Stock Topples
09:02am, Friday, 03'rd Feb 2023
Regeneron Pharma beat quarterly forecasts Friday, but its partner Sanofi posted a mixed report. Regeneron stock rose as SNY stock toppled.
Stocks to Watch in Europe: Chipmakers, Sanofi, Zur Rose
03:47am, Friday, 03'rd Feb 2023
Bloomberg's Joe Easton has a rundown of the stocks to keep an eye on in Europe today, including pharma firms Sanofi and Zur Rose, and chipmakers ASML, Infineon, and STMicroelectronics. Follow Bloomber
Sanofi profit narrowly beats forecasts, sees stronger earnings growth in 2023
02:00am, Friday, 03'rd Feb 2023
Sanofi SA on Friday posted rising earnings and sales for the fourth quarter and said it expects its earnings per share to grow in 2023.
Is a Surprise Coming for Sanofi (SNY) This Earnings Season?
09:47am, Thursday, 02'nd Feb 2023
Sanofi (SNY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
SNY or NVO: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 01'st Feb 2023
SNY vs. NVO: Which Stock Is the Better Value Option?
Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts
11:04am, Tuesday, 31'st Jan 2023
The layoff trend has carried into 2023, and it isn't confined to the tech sector. French pharmaceutical producer Sanofi SA (NASDAQ: SNY ) has reported that it plans to let go of all staff at two vacci
